C-VQKQProsetta
small molecules, assembly modulation, multi-protein complexes
modulatingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-VQKQ
C-VQKQC-VQKQsmall molecules, assembly modulation, multi-protein complexes
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Prosetta small molecules, assembly modulation, multi-protein complexes
Prosetta Biosciences is a San Francisco based biotechnology company creating innovative therapeutics for diseases. Its work focuses on identifying and advancing novel small molecules that modulate assembly of multi-protein complexes within cells. The company describes assembly-modulators as working with the body's regulatory mechanisms to restore molecular homeostasis.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Prosetta — Early mechanism · Lower middle. Derived deterministically from 9 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Modifiers: +5 depth (3 programs at preclinical).…
Source: Deterministic